LRP8

Chr 1

LDL receptor related protein 8

Also known as: APOER2, HSZ75190, LRP-8, MCI1

The LRP8 protein functions as a cell surface receptor for Reelin and apolipoprotein E, playing a critical role in neuronal migration and layering during embryonic brain development through the Reelin signaling pathway. Mutations in LRP8 are associated with susceptibility to myocardial infarction with autosomal dominant inheritance. This gene is highly constrained against loss-of-function mutations, suggesting that complete loss of LRP8 function may be incompatible with normal development.

OMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismLOEUF 0.221 OMIM phenotype
Clinical SummaryLRP8
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
10 unique Pathogenic / Likely Pathogenic· 116 VUS of 174 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint
0.22LOEUF
pLI 1.000
Z-score 5.67
OE 0.11 (0.060.22)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
2.52Z-score
OE missense 0.70 (0.640.76)
382 obs / 548.0 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.11 (0.060.22)
00.351.4
Missense OE0.70 (0.640.76)
00.61.4
Synonymous OE0.88
01.21.6
LoF obs/exp: 5 / 46.9Missense obs/exp: 382 / 548.0Syn Z: 1.45
DN
0.4389th %ile
GOF
0.7028th %ile
LOF
0.62top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFLOEUF 0.22
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

174 submitted variants in ClinVar

Classification Summary

Pathogenic7
Likely Pathogenic3
VUS116
Likely Benign19
Benign8
Conflicting1
7
Pathogenic
3
Likely Pathogenic
116
VUS
19
Likely Benign
8
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
7
0
7
Likely Pathogenic
0
0
3
0
3
VUS
0
113
3
0
116
Likely Benign
0
9
5
5
19
Benign
0
0
1
7
8
Conflicting
1
Total01221912154

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

LRP8 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →